Skip to main content

CON-TGO91-190 - Bayer Australia Ltd

Product names
  • AUST R 97219 - VENTAVIS iloprost 10 microgram/mL solution for inhalation ampoule
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 31 January 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site